Description
Carditab (Phenobarbital) Sublingual Tablets №10
Composition
Each Carditab tablet contains phenobarbital as the active ingredient. Phenobarbital, a barbiturate, is primarily used in the treatment of epilepsy and related seizure disorders.
Mechanism of Action
Phenobarbital acts as a central nervous system depressant by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter. This results in decreased neuronal excitability, thereby reducing the frequency and severity of seizures.
Pharmacological Properties
Phenobarbital exhibits anticonvulsant properties by modulating GABA receptors and inhibiting excitatory neurotransmission. It also possesses sedative effects due to its impact on the central nervous system.
Indications for Use
Carditab (Phenobarbital) Sublingual Tablets are indicated for the treatment of epilepsy and seizure disorders. They are recommended for patients requiring anticonvulsant therapy to manage their condition effectively. Additionally, these tablets may be prescribed for other neurological conditions under the supervision of a healthcare professional.
Contraindications
Carditab (Phenobarbital) Sublingual Tablets are contraindicated in patients with a known hypersensitivity to barbiturates, including phenobarbital. Individuals with a history of porphyria should also avoid the use of this medication due to the risk of exacerbating the condition.
Side Effects
Common side effects associated with Carditab (Phenobarbital) Sublingual Tablets may include drowsiness, dizziness, nausea, and cognitive impairment. In some cases, long-term use of phenobarbital may lead to tolerance, dependence, or withdrawal symptoms upon discontinuation.
Usage Instructions
For optimal therapeutic outcomes, it is recommended to take one Carditab tablet sublingually once daily, or as directed by your healthcare provider. Place the tablet under the tongue and allow it to dissolve completely. Refrain from swallowing the tablet whole to ensure proper absorption of the medication. Consult your healthcare provider if you experience any difficulties with sublingual administration.
Benefits Compared to Analogues
Carditab (Phenobarbital) Sublingual Tablets offer a convenient and effective treatment option for patients requiring anticonvulsant therapy. Compared to other antiepileptic drugs, phenobarbital has a long history of use, proven efficacy, and cost-effectiveness, making it a preferred choice for certain patient populations.
Suitable Patient Groups
Carditab (Phenobarbital) Sublingual Tablets are suitable for adults and pediatric patients with epilepsy or seizure disorders. Elderly individuals may also benefit from the therapeutic effects of phenobarbital, provided proper dosage adjustments are made based on individual health status and medication tolerance.
Storage and Shelf Life
Store Carditab (Phenobarbital) Sublingual Tablets in a cool, dry place away from direct sunlight and moisture. Keep the tablets in their original packaging to protect them from environmental factors. Check the expiration date on the packaging and do not use the tablets beyond the specified shelf life.
Packaging Description
Carditab (Phenobarbital) Sublingual Tablets are typically packaged in blister packs containing 10 tablets per pack. Each tablet is individually sealed to maintain product integrity and ensure accurate dosing. The packaging is designed to provide convenience and protection for the tablets during storage and transportation.
